Document is current
Any future updates will be listed below
-
Authors
Averill, Ian R. E.
Beaglehole, Ben
Douglas, Katie M.
Jordan, Jennifer
Crowe, Marie T.
Inder, Maree
Lacey, Cameron J.
Frampton, Christopher M.
Bowie, Christopher R.
Porter, Richard J.
-
Funding
Funding for this research was provided by:
Canterbury Medical Research Foundation
Health Research Council of New Zealand (18/152)
- License Information
-
More Information
Article History
Received: 10 August 2018
Accepted: 25 January 2019
First Online: 1 February 2019
Ethics approval and consent to participate
: Ethics approval was granted for the pilot study from the University of Otago Human Ethics Committee (Health) (Approval No: H15/056). Ethical approval for the proposed study was granted on 1 June 2018 (reference []/NTB/75) by the Health and Disability Ethics Committees (Northern B), Ministry of Health, 133 Molesworth Street, P.O. Box 5013, Wellington, New Zealand, 6011. All participants provided written informed consent.
: Not applicable.
: Professors Porter and Bowie use Software for research at no cost from Scientific Brain Training Pro. Professor Porter has received support for travel to educational meetings from Servier and Lundbeck.Professor Bowie is a Consultant or Board Member for Takeda, Boehringer Ingelheim, Lundbeck, Otsuka and receives grant Support from Pfizer, Takeda.All other authors have no competing interests to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
